Showing results (51-60 of 115) with videos related to
Sort By:
Pageof 12
Journal of Clinical Pharmacology|February 1, 1983
Pharmacokinetic principles of antineoplastic drug therapyL M AllenCancer Research|June 1, 1982
Toxicity and pharmacokinetics of a new antifolate, 2,4-diamino-5-adamantyl-6-methylpyrimidine, in dogsS F Zakrzewski, Z Pavelic, W R Greco, et al.Cancer Research|July 1, 1980
Colony growth in soft agar of human melanoma, sarcoma, and lung carcinoma cells disaggregated by mechanical and enzymatic methodsZ P Pavelic, H K Slocum, Y M Rustum, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
Uptake and metabolism of iproplatin in murine L1210 cellsL Pendyala, J R Walsh, M M Huq, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinomaF Trave, Y M Rustum, N J Petrelli, et al.Cancer Letters|July 19, 1996
Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cellsZ el-akawi, M Abu-hadid, R Perez, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of recombinant human tumor necrosis factorP J Creaven, J E Plager, S Dupere, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
Studies on the human metabolism of iproplatinL Pendyala, B S Krishnan, J R Walsh, et al.Cancer Treatment Reports|September 1, 1983
Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP)P J Creaven, S Madajewicz, L Pendyala, et al.Investigational New Drugs|January 1, 1997
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancyP J Creaven, R Perez, L Pendyala, et al.Pageof 12